Orchid Pharma Ltd
Ticker: ORCHPHARMA
Risky
48/100
☆ Add to Watchlist
Investing Reference
Price
721.95
Market Cap
3661.67
Debt/Equity
0.1378
ROE %
8.180
PB
2.8894
Promoter %
69.836
Pledge %
0.000
1Y Rev Growth %
11.664
5Y Rev Growth %
13.319
NP Margin %
10.497
NP Margin 5Y Avg %
0.474
Trading Reference
1M Return %
2.664
6M Return %
-4.460
1Y Return %
-47.059
% Away 52W High
176.667
% Away 52W Low
19.568
Daily Volume
71352
Investment Verdict
Hold
Score 67/100 · Position size: 30%
Fundamentals are OK but not compelling. Maintain current position; avoid fresh adds.
Trading Verdict
Avoid
Score 18/100 · Position size: 0%
Momentum weak or trend adverse. Avoid trading at this point.
Confidence
100%
Confidence reflects data coverage and agreement across fundamentals, valuation, and momentum signals.
AI Probability Statement
Probability Statement
Orchid Pharma Ltd is currently trading near a key support level, with the 50-day EMA indicating a bullish trend. If it breaks above the resistance level, there is potential for a significant upside. However, if it falls below the support, a downside risk is present.
Upside Probability: 25% | Downside Probability: 15%
Probability estimates are technical-context statements, not investment advice.
More Options
S
Sagar Cements Ltd
Sagar Cements Ltd shows potential for growth in a vital sector, but faces challenges in profitability and execution risks.
View details
E
Epack Durable Ltd
Epack Durable Ltd shows potential in a growing sector, but faces challenges in profitability and valuation metrics. Caution is advised for investors.
View details
U
Ujaas Energy Ltd
Ujaas Energy Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment.
View details
M
Medi Assist Healthcare Services Ltd
Medi Assist Healthcare Services Ltd shows potential for growth, but faces challenges in profitability and valuation metrics.
View details
U
Unichem Laboratories Ltd
Unichem Laboratories has a decent score, indicating potential but with notable risks and inconsistencies in growth and profitability.
View details
H
HLE Glascoat Ltd
HLE Glascoat Ltd shows a decent investment opportunity with solid growth and profitability metrics, though some risks and valuation concerns exist.
View details
G
Goodluck India Ltd
Goodluck India Ltd shows decent potential for growth, but faces challenges in profitability and valuation metrics.
View details
B
BN Agrochem Ltd
BN Agrochem Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment.
View details
S
Sambhv Steel Tubes Ltd
Sambhv Steel Tubes Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
K
Kalyani Steels Ltd
Kalyani Steels Ltd shows potential in a critical sector, but faces challenges in growth consistency and market sentiment.
View details
D
D P Abhushan Ltd
D P Abhushan Ltd shows potential but faces several challenges that could impact future performance.
View details
G
Ganesha Ecosphere Ltd
Ganesha Ecosphere Ltd shows potential in a future-ready sector but faces challenges in profitability and execution risks.
View details
B
Bharat Bijlee Ltd
Bharat Bijlee Ltd shows potential in a future-ready sector but faces challenges in growth consistency and valuation metrics.
View details
K
Kiri Industries Ltd
Kiri Industries Ltd shows potential in a growing sector, but faces challenges in consistency and valuation. Caution is advised.
View details
I
Interarch Building Solutions Ltd
Interarch Building Solutions Ltd shows potential for growth in a promising sector, but faces challenges in profitability and valuation metrics.
View details
N
National Standard (India) Ltd
The stock presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
Business Overview
Orchid Pharma Ltd is a leading Indian pharmaceutical company specializing in the development and manufacturing of high-quality generic medicines. With a commitment to innovation and excellence, Orchid Pharma serves healthcare providers and patients, ensuring access to affordable treatments. The company plays a crucial role in the global pharmaceutical landscape, focusing on complex generics and active pharmaceutical ingredients (APIs).
- Established player in the Indian pharma sector
- Focus on high-quality generic medicines
- Strong commitment to research and development
- Global presence with a diverse product portfolio
- Dedicated to improving healthcare accessibility
Investment Thesis
Orchid Pharma Ltd presents a compelling investment opportunity due to its strong promoter credibility, significant growth potential in digital services, and attractive valuation compared to peers. These factors position the company for robust future performance in the pharmaceutical sector.
- Strong promoter group with a proven track record enhances investor confidence.
- Expansion in digital services opens new revenue streams and growth avenues.
- Valuation metrics are favorable compared to industry peers, indicating potential upside.
- Focus on R&D and innovation strengthens competitive positioning in the market.
- Strategic partnerships and collaborations may further drive growth and market reach.
Opportunity vs Risk
Opportunities
- Strong product pipeline
- Growing demand for generics
- Potential for international expansion
- Strategic partnerships with healthcare firms
Risks ⚠️
- Regulatory challenges in pharma
- High competition in generics
- Debt levels impacting cash flow
- Market volatility affecting stock price
Peer Perspective
Orchid Pharma Ltd trades at a discount compared to peers like Sun Pharma and Dr. Reddy's, primarily due to margin volatility; a focus on stabilizing margins and enhancing growth could trigger a rerating.
Future Outlook
Orchid Pharma Ltd is poised for growth, driven by its strategic initiatives and expanding product pipeline; however, successful execution and stringent cost control will be essential to fully realize its potential in the competitive pharmaceutical landscape.
AI FAQs for Retail Users
- Q: What does Orchid Pharma Ltd do?A: Orchid Pharma Ltd is a pharmaceutical company focused on manufacturing and marketing generic drugs.
- Q: Is Orchid Pharma Ltd listed on stock exchanges?A: Yes, Orchid Pharma Ltd is listed on the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE) in India.
- Q: What are the key products of Orchid Pharma Ltd?A: The company specializes in antibiotics, anti-infectives, and other therapeutic segments.
- Q: How can I invest in Orchid Pharma Ltd?A: You can invest by purchasing shares through a registered stockbroker or online trading platform.
- Q: What are the risks of investing in Orchid Pharma Ltd?A: As with any stock, risks include market volatility, regulatory changes, and company performance.
📊 Stock Investment Checklist (100 Points)
Orchid Pharma Ltd • Updated: 2025-09-17 06:00:11
-
8BusinessHighPharmaceutical sector shows potential but faces regulatory challenges.
-
10GrowthHighInconsistent revenue growth due to market competition.
-
7ProfitabilityHighModerate ROE and ROCE, cash flow issues noted.
-
6ValuationGoodValuation metrics are above industry average.
-
5BalanceGoodHigh debt levels compared to equity.
-
6GovernanceGoodPromoter holding is decent but some pledging observed.
-
4DriversGoodLimited growth drivers and high execution risks.
-
2TechnicalsLowWeak market sentiment and low liquidity.
Final Score & Verdict
Score 48 / 100
• Risky
Orchid Pharma Ltd presents several risks with inconsistent growth and high debt levels, making it a risky investment.
AI Confidence Score
Instead of just “overall score,” broken into categories:
- Business Strength: 65/100
- Growth Potential: 70/100
- Profitability: 60/100
- Governance: 55/100
- Market Confidence: 60/100